Cutler Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,100
Closed -$3K 5498
2022
Q3
$3K Sell
1,100
-700
-39% -$2.98K ﹤0.01% 4099
2022
Q2
$8K Sell
1,800
-12,030
-87% -$63K ﹤0.01% 3418
2022
Q1
$98K Buy
13,830
+12,130
+714% +$100K 0.01% 1731
2021
Q4
$30K Sell
1,700
-1,000
-37% -$21.6K ﹤0.01% 2817
2021
Q3
$52K Buy
+2,700
New +$103K ﹤0.01% 2484

Other funds holding CELL

Cutler Group's CELL Position: Q4 2022 in Review

Cutler Group sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 1,100 shares — an estimated $3K sold.

Cutler Group first reported a position in CELL in Q3 2021 and held it in 5 quarters. The position peaked at $98K in Q1 2022. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.

  • Cutler Group reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 1,100 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Cutler Group first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Cutler Group's PhenomeX Inc. Common Stock position peaked at $98K in Q1 2022.
  • 117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.